DMA110: Demystifying Market Access in the South African Healthcare Environment

Developed and authored by Mark Brand

Course Summary

Medical device registration e.g. FDA and CE, which are critical quality, safety and efficacy indicators, are merely authorizations to sell a technology, and the absolute minimum requirement for market access, but are not a guarantee for adoption and/or reimbursement; policy makers demand more!

Introducing new technologies to the South Africa Healthcare market is a daunting task, given the potential roadblocks presented by payers and policy makers to manage utilization and health care costs. Although it has a market access focus, this workshop is not exclusively for market access personnel, and every level of business decision-maker will benefit by attending.

Why should you attend?

  • If product and procedure reimbursement is a key factor for successful market access.
  • understand processes that could reduce time bringing products to market.
  • If you are looking at a strategic approach to market access to optimise efficiencies.
  • If you need to successfully communicate a value proposition for your technology.
  • If you want to be part of the solution, not the problem, of managing the business of health care cost effectively.

Who should attend?

Any medical device company representative who is involved in introducing new health technologies to the market, including:

  • Chief Executives,
  • Business Unit Managers,
  • Product Managers,
  • Marketing Managers and
  • Market Access Managers.

Programme

  • Information session: 2 March 2023

    Where and how HTA can support patient access to innovation

    Inviting all Medical Technology colleagues wishing to gain perspective on:

    • Importance of using HTA for medical devices
    • How HTA can promote patient access to innovative medical devices
    • What role can industry play in expediting HTA decision making
  • Study Unit 1: Navigating the South African Healthcare Environment

    Provide:

    • A background to the SA healthcare industry
    • Key industry demographics and relevant economic indicators
    • An understanding of the industry structure and relationships
    • Current industry dynamics that are worth watching
    • Macro environmental factors that may influence the market
    • The ability to navigate market access hurdles and processes
  • Study Unit 2: Health Technology Management

    Provide:

    • A framework for Heath Technology Management (HTM) and how to manage the technology life-cycle
    • Knowledge of where Health Technology Assessment (HTA) fits into the above framework and how it may offer a strategic approach to introducing and/or repositioning health technologies
    • Context for where HTM fits into the health technology regulatory framework of South Africa
    • Insight into three distinct components of HTM and unpacking these in the context of business
      • Pre-HTA: pre-launch activities (in fact, a decision to launch can be made after this time)
      • HTA: unpacking the clinical message and value proposition
      • Post HTA
    • A continuous but closed loop (not linear) approach to managing health technologies
  • Study Unit 3: Developing a Market Access Strategy

    Provide:

    • Knowledge on how to efficiently align business and reimbursement strategies
    • A systemic approach to developing a market access strategy for any health technology, as aligned with the company's business strategy
    • An understanding of who the various stakeholders are in the decision making process, their respective influence on each other and your market access strategy
    • A framework for defining a meaningful value proposition to each relevant stakeholder
    • A guide on collating the information and creating the "dossier"
  • 3-weeks

    Duration - April-May

  • Certificate

    of completion awarded

  • 15 hours

    Study time

  • Fees (excl VAT)

    R3740 Corp Members
    R3975 Stand Members
    R4210 Ind Members
    R4675 Non Members

  • 3 live sessions

    with Mark Brand via Zoom

Meet the Course Developer and Author

Mark Brand

Mark Brand

Independent HTA Consultant; MBA; Electrical Engineering; HTA (USB)

Click on image for bio

Scheduled Events

Please note that dates, topics and presenters are subject to change.

Feb
8
Wed
8:30 am Virtual CPD – 8 February 2023 (P...
Virtual CPD – 8 February 2023 (P...
Feb 8 @ 8:30 am – 10:15 am
Virtual CPD - 8 February 2023 (POSTPONED from 31/01)
Programme 08h55: Login and sound check 09h00: Reaching remission in theory and practicePresented by: Dr Elsa van Duuren (Rheumatologist) 10h05: Wrap up Link to register Thank you to Eli Lilly for providing the unconditional educational sponsorship,…
Feb
9
Thu
8:30 am Virtual CPD – 9 February 2023 @ Zoom - link to register available in the invitation
Virtual CPD – 9 February 2023 @ Zoom - link to register available in the invitation
Feb 9 @ 8:30 am – 10:30 am
Virtual CPD - 9 February 2023 @ Zoom - link to register available in the invitation | Sandton | Gauteng | South Africa
Programme 08h55: Login and sound check 09h00: Tba Presented by: Tba (Tba) 10h05: Wrap up Link to register (Tbc) Attendance free for PTCMA members and HPCSA Medical Practitioners only – not open for Non-Members unless…
Feb
10
Fri
8:30 am Virtual CPD – 10 February 2023
Virtual CPD – 10 February 2023
Feb 10 @ 8:30 am – 10:15 am
Virtual CPD - 10 February 2023
Programme 08h55: Login and sound check 09h00: Tba Presented by: Tba (Tba) 10h05: Wrap up Link to register (Tbc) Attendance free for PTCMA members and HPCSA Medical Practitioners only – not open for Non-Members unless…

Latest Newsletter

Find us on